KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Treasury Shares (2018 - 2025)

Pacific Biosciences Of California has reported Treasury Shares over the past 8 years, most recently at $392000.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $392000.0 for Q4 2025, down 97.24% from a year ago — trailing twelve months through Dec 2025 was $392000.0 (down 97.24% YoY), and the annual figure for FY2025 was $392000.0, down 97.24%.
  • Treasury Shares for Q4 2025 was $392000.0 at Pacific Biosciences Of California, roughly flat from $392000.0 in the prior quarter.
  • Over the last five years, Treasury Shares for PACB hit a ceiling of $21.4 million in Q1 2025 and a floor of $8392.0 in Q2 2022.
  • Median Treasury Shares over the past 5 years was $6.5 million (2021), compared with a mean of $6.3 million.
  • Biggest five-year swings in Treasury Shares: plummeted 99.88% in 2022 and later soared 150555.39% in 2023.
  • Pacific Biosciences Of California's Treasury Shares stood at $7.4 million in 2021, then grew by 15.46% to $8.5 million in 2022, then plummeted by 93.66% to $541000.0 in 2023, then skyrocketed by 2526.8% to $14.2 million in 2024, then plummeted by 97.24% to $392000.0 in 2025.
  • The last three reported values for Treasury Shares were $392000.0 (Q4 2025), $392000.0 (Q3 2025), and $392000.0 (Q2 2025) per Business Quant data.